- Home
- GENK vs MODD Comparison
GENK vs MODD Comparison
Compare GENK & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENK | MODD |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | 2700 | N/A |
| Industry | Restaurants | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 11.2M |
| IPO Year | 2023 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GENK | MODD |
|---|---|---|
| Price | $1.67 | $2.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | 63.6K | ★ 165.0K |
| Earning Date | 05-13-2026 | 02-17-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | ★ 62.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $208,380,000.00 | N/A |
| Revenue This Year | $4.79 | N/A |
| Revenue Next Year | $7.48 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.12 | N/A |
| 52 Week Low | $1.43 | $0.12 |
| 52 Week High | $3.21 | $6.16 |
Technical Indicators
Market Signals| Indicator | GENK | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 36.23 | 39.83 |
| Support Level | $1.49 | $0.29 |
| Resistance Level | $1.73 | $2.49 |
| Average True Range (ATR) | 0.11 | 0.37 |
| MACD | -0.03 | -0.12 |
| Stochastic Oscillator | 31.91 | 8.28 |
Price Performance
Historical ComparisonAbout GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. The group operates its restaurants in California, Arizona, Hawaii, Nevada, Texas, New York, Oregon, North Carolina, Washington, New Jersey, Florida and South Korea.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, marketing and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.